OSSTEC

OSSTEC is a London-based medtech startup that specializes in innovative 3D-printed orthopedic implants, particularly next-generation knee replacements designed to mimic bone properties. Founded in May 2021 by Dr. Maxwell Munford, the company emerged from research at Imperial College London and focuses on improving patient outcomes in osteoarthritis treatment.

The company develops partial knee implants featuring 3D-printed articulating surfaces and biomimetic cementless fixation. These implants utilize lattice titanium structures to enhance fixation, stimulate healthy tissue growth, and reduce complications. OSSTEC has achieved significant milestones, including successful pre-clinical validation through animal studies and human cadaveric tests. The team consists of engineers, surgeons, and commercial experts, and the company is actively pursuing regulatory approval for clinical use. OSSTEC has secured substantial funding to support its development and market launch efforts.